• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Local UK radio interview transcript with Fluge and Mella

Simon

Senior Member
Messages
3,789
Location
Monmouth, UK
Thanks to Russell Fleming for the transcript
Fluge/Mella said:
So then we did an open-label study with no placebo group with a maintenance treatment of further

Rituximab infusion prolonging the period of no B-cells we gave six infusions of Rituximab up to

fifteen months and then followed the patients for three years.

This study is now submitted for publication but we can say that again two-thirds had a clinical

response and their response durations were much prolonged when we gave maintenance

treatment.
delete too if needed